LRCX

Lam Research Corporation (10-K) Summary

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended June 30, 1996. Lam Research Corporation designs, manufactures, and services semiconductor processing equipment, specifically for deposition and etch processes used in integrated circuit fabrication. The company operates globally with significant manufacturing and R&D facilities in the United States, Japan, and South Korea. As of August 30, 1996, the company had approximately 4,500 employees and 30,298,633 shares of Common Stock outstanding.

Key Financial Metrics

While specific revenue and net income figures are incorporated by reference to the 1996 Annual Report to Stockholders and not explicitly detailed in the text of this filing, the following financial data points are provided:

• Research & Development (R&D): Net R&D expenses for fiscal 1996 were approximately $173.0 million, representing 13.6% of total revenue. This compares to $127.8 million (15.8%) in 1995 and $76.3 million (15.5%) in 1994.
• Order Backlog: As of June 30, 1996, the order backlog was approximately $328.0 million, an increase from $252.6 million as of June 30, 1995.
• Product Mix: Sales of etch systems contributed approximately 77% of total revenues in fiscal 1996 (consistent with 77% in 1995 and 78% in 1994).
• Export Sales: Export sales accounted for approximately 41% of net sales in fiscal 1996.
• Reserves: The product warranty and improvement reserve balance increased to $62.18 million at June 30, 1996, from $40.99 million in the prior year.
• Market Value: The aggregate market value of voting stock held by non-affiliates was approximately $604.1 million as of August 30, 1996.

Note: Specific values for total revenue, net profit, operating cash flow, and total debt are not explicitly stated in the provided text and are incorporated by reference to the Annual Report to Stockholders.

Material Changes and Operational Updates

• Restructuring: In August 1996, the company announced a restructuring to consolidate business units into centralized functional organizations. This resulted in a workforce reduction of approximately 11%. A restructuring charge of $11.0 to $12.0 million is expected to be recorded in the first quarter of fiscal 1997, primarily for severance and facility consolidation.
• Facility Expansion: The company completed a manufacturing facility in CheonAn, Korea, in July 1995. In fiscal 1996, it expanded its Japan facility and began construction of a second facility in Sagamihara, Japan, in July 1996.
• Customer Concentration: In fiscal 1996, no single customer accounted for more than 10% of total revenue. This contrasts with fiscal 1995, where Intel accounted for 11% and Motorola for 10%.
• Product Launches: The company introduced the DSM 9900 High Density Plasma (HDP) CVD system in November 1995.

Outlook, Risks, and Contingencies

Management Commentary and Outlook: The semiconductor industry is currently experiencing a slowdown in product demand and volatility in pricing, leading customers to exercise caution in capital equipment purchases. Some orders have been rescheduled or cancelled. Management anticipates continued substantial investment in R&D to maintain competitive positioning.

Key Risks and Contingencies:

• Industry Cyclicality: Revenue is highly dependent on the capital expenditures of semiconductor manufacturers, which are cyclical. Future downturns could materially adversely affect results.
• Competition: The industry is highly competitive with major players like Applied Materials, Inc., Tokyo Electron Limited (TEL), and Hitachi Ltd. Competitors have greater financial resources.
• Technology Obsolescence: Rapid technological change requires timely development of new products. Failure to do so could render current offerings obsolete.
• Legal Proceedings: Varian Associates, Inc. sued the company in October 1993 for alleged patent infringement. The company believes this will not have a material adverse effect on financial statements, but litigation outcomes are uncertain.
• International Operations: Significant exposure to international risks including tariffs, staffing difficulties, and foreign currency fluctuations.

Investor Verification Checklist

• Verify the specific total revenue and net income figures for fiscal 1996, 1995, and 1994 in the incorporated 1996 Annual Report to Stockholders (pages 14-19).
• Confirm the impact of the $11.0–$12.0 million restructuring charge on the first quarter of fiscal 1997 earnings.
• Monitor the status of the Varian Associates patent litigation for potential future liabilities or licensing costs.
• Assess the order backlog conversion rate given the industry slowdown and history of order cancellations/rescheduling.
• Review the cash flow statement to determine liquidity position and debt obligations, as these are not detailed in the text provided.